Stenvinkel, Peter
Painer, Johanna
Kuro-o, Makoto
Lanaspa, Miguel
Arnold, Walter
Ruf, Thomas
Shiels, Paul G.
Johnson, Richard J.
Article History
First Online: 15 January 2018
Competing interests
: P. S. received grants and honoraria from Baxter, Bayer, Astra Zeneca, Bristol-Myers Squibb, Pfizer, Akeiba and Corvidia. M.K. has received grants and honoraria from Bayer, Astellas, Bristol-Myers Squibb and Kissei Pharmaceuticals. R.J.J. has grants from the US National Institutes of Health (NIH), Department of Defense and the Veteran's Administration. He is also a member of Colorado Research Partners, LLC, which is developing inhibitors of fructose metabolism. The other authors declare no competing interests.